Pivekimab sunirine (IMGN632), a novel CD123-targeting antibody–drug conjugate, in relapsed or refractory acute myeloid leukaemia: a phase 1/2 study
- Resource Type
- Article
- Authors
- Daver, Naval G ; Montesinos, Pau; DeAngelo, Daniel J; Wang, Eunice S; Papadantonakis, Nikolaos; Todisco, Elisabetta; Sweet, Kendra L; Pemmaraju, Naveen; Lane, Andrew A; Torres-Miñana, Laura; Thompson, James E; Konopleva, Marina Y; Sloss, Callum M; Watkins, Krystal; Bedse, Gaurav; Du, Yining; Malcolm, Kara E; Zweidler-McKay, Patrick A; Kantarjian, Hagop M
- Source
- In The Lancet Oncology March 2024 25(3):388-399
- Subject
- Primary Research
Articles
- Language
- ISSN
- 1470-2045